Trade

with

Endo International PLC
(NASDAQ: ENDP)
AdChoices
64.42
+0.69
+1.08%
After Hours :
-
-
-

Open

63.77

Previous Close

63.73

Volume (Avg)

4.80k (2.08M)

Day's Range

63.59-64.42

52Wk Range

43.12-82.16

Market Cap.

9.78B

Dividend Rate ( Yield )

-

Beta

1.14

Shares Outstanding

153.47M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 2.62B

    • Net Income

    • -685.34M

    • Market Cap.

    • 9.78B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -44.99

    • PEG (Price/Earnings Growth) Ratio

    • 1.31

    • Beta

    • 1.14

    • Forward P/E

    • 14.58

    • Price/Sales

    • 3.17

    • Price/Book Value

    • 3.48

    • Price/Cash flow

    • 59.52

      • EBITDA

      • -128.98M

      • Return on Capital %

      • -14.03

      • Return on Equity %

      • -57.57

      • Return on Assets %

      • -14.03

      • Book Value/Share

      • 18.29

      • Shares Outstanding

      • 153.47M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 78.00

        • Credit Rating

        • BB

        • Analysts

        • 8

        • EPS Estimate

        • 2.29

        • Cashflow Estimate

        • 4.42

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.90

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -15.00

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 15.73

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 56.66

            • 64.72

            • Pre-Tax Margin

            • -49.86

            • 13.77

            • Net Profit Margin

            • -44.99

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 64.90

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 3.20

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -2.10

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 1.51

              • 0.33

              • Current Ratio

              • 1.45

              • 1.52

              • Quick Ratio

              • 1.11

              • 0.87

              • Interest Coverage

              • -5.53

              • 6.77

              • Leverage Ratio

              • 3.55

              • 1.91

              • Book Value/Share

              • 18.29

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -7.34

                • 63.69

                • P/E Ratio 5-Year High

                • -10.02

                • 237.47

                • P/E Ratio 5-Year Low

                • -2.33

                • 19.71

                • Price/Sales Ratio

                • 3.00

                • 3.57

                • Price/Book Value

                • 3.29

                • 3.35

                • Price/Cash Flow Ratio

                • 59.52

                • 21.41

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -57.57

                    (-17.60)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -14.03

                    (0.50)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -17.35

                    (-2.50)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • 2.59

                  • 1.80

                  • Asset Turnover

                  • 0.31

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -425.62M
                  Operating Margin
                  -16.26
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  59.52
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  46.52%

                  Mutual Fund Ownership

                  45.28%

                  Float

                  99.51%

                  5% / Insider Ownership

                  2.36%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Janus Contrarian Fund

                  •  

                    4,116,441

                  • 5.15

                  • 2.70

                  • VA CollegeAmerica Small Cap World

                  •  

                    2,900,518

                  • -6.08

                  • 1.89

                  • VA CollegeAmerica AMCAP

                  •  

                    2,837,798

                  • 0.00

                  • 1.85

                  • Morgan Stanley Inst Mid Cap Growth Port

                  •  

                    2,792,987

                  • -1.90

                  • 1.83

                  • Vanguard Mid-Cap Index Fund

                  •  

                    2,625,558

                  • 7.26

                  • 1.71

                  • Vanguard Total Stock Mkt Idx

                  •  

                    2,496,157

                  • 6.57

                  • 1.63

                  • Goldman Sachs Mid Cap Value Fund

                  •  

                    2,223,425

                  • 127.75

                  • 1.45

                  • iShares Core S&P Mid-Cap (AU)

                  •  

                    2,094,050

                  • -0.36

                  • 1.23

                  • iShares Nasdaq Biotechnology

                  •  

                    2,035,443

                  • -0.69

                  • 1.19

                  • Vanguard Extended Market Index Fund

                  •  

                    1,402,799

                  • 7.73

                  • 0.91

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Capital Research Global Investors

                  •  

                    14,757,040

                  • +0.68%

                  • 9.66

                  • Janus Capital Management LLC

                  •  

                    12,349,226

                  • +2.20%

                  • 8.08

                  • Vanguard Group, Inc.

                  •  

                    8,823,401

                  • +2.28%

                  • 5.78

                  • Blue Ridge CapHldgsLLC/BluRdgCapOSHldgs

                  •  

                    6,815,000

                  • -14.81%

                  • 4.47

                  • Morgan Stanley Investment Management Inc

                  •  

                    5,239,332

                  • -1.10%

                  • 3.43

                  • State Street Corp

                  •  

                    4,613,049

                  • +13.30%

                  • 3.02

                  • Visium Asset Management LLC

                  •  

                    4,598,007

                  • +29.79%

                  • 3.01

                  • Glenview Capital Management LLC

                  •  

                    3,930,472

                  • +100.11%

                  • 2.58

                  • MFS Investment Management K.K.

                  •  

                    3,852,174

                  • -0.27%

                  • 2.52

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Mid Core

                  Endo International PLC was formed on October 31, 2013. It is a specialty healthcare company engaged in developing, manufacturing, marketing and distributing branded pharmaceutical and generic products as well as medical devices. Its current portfolio is associated with a set of therapeutic areas including, Allergy Immunotherapy, Central Precocious Puberty, Dermatology, Insomnia, Pain, Pelvic Health, Urology and Women's Health.

                  Key People

                  Mr. Rajiv De Silva

                  Director/President/CEO

                  Mr. Roger H. Kimmel

                  Director/Chairman of the Board

                  Mr. Suketu Upadhyay

                  CFO/Executive VP

                  Caroline B. Manogue

                  Executive VP/Secretary/Other Executive Officer

                  Daniel Rudio

                  Controller/Vice President/Chief Accounting Officer

                  • Endo International PLC

                  • 33 Fitzwilliam Square

                  • Dublin, 2

                  • IRL.Map

                  • Phone: +353 16994700

                  • Fax: -

                  • endo.com

                  Incorporated

                  2013

                  Employees

                  3,371

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: